Announcements Trials
Browse Landscape

Status

Recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 15Carcinoma, Renal Cell 5Urinary Bladder Neoplasms 2Rhabdoid Tumor 2Wilms Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms, Castration-Resistant 1Progressive Metastatic Castrate Resistant Prostate Cancer 1Pinealoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Disease 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Progressive Metastatic Castrate Resistant Prostate Cancer × Genitourinary × Clear all
NCT03386071 2019-01-16

Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib

Jonsson Comprehensive Cancer Center

No longer available
Genitourinary

Progressive Metastatic Castrate Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡